Oruka Therapeutics, Inc. Share-based Payment Arrangement, Expense
Oruka Therapeutics, Inc. (ORKA) reported Share-based Payment Arrangement, Expense of $7.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-10
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $7.28M, a 43.47% increase year-over-year.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $6.97M, a 42.70% increase year-over-year.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.12M.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $10.16M, a 12.93% increase year-over-year.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2025 was $24.24M.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $686.00K, a 23.38% increase from fiscal 2022.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $556.00K, a 11.87% increase from fiscal 2021.
- Oruka Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $497.00K, a 1055.81% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Expense 2 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 5 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 8 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 11 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 126 month | Share-based Payment Arrangement, Expense 129 month | Share-based Payment Arrangement, Expense 132 month | Share-based Payment Arrangement, Expense 135 month | Share-based Payment Arrangement, Expense 138 month | Share-based Payment Arrangement, Expense 141 month | Share-based Payment Arrangement, Expense 144 month | Share-based Payment Arrangement, Expense 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.28M 10-Q · filed 2026-08-10 | $14.25M 10-Q · filed 2026-08-10 | $18.37M derived: sum of 3 quarters · filed 2026-08-10 | $28.53M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2026-03-31 | $6.97M 10-Q · filed 2026-05-13 | $11.08M derived: sum of 2 quarters · filed 2026-05-13 | $21.25M derived: sum of 3 quarters · filed 2026-05-13 | $26.32M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-12-31 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $14.28M derived: sum of 2 quarters · filed 2026-03-12 | $19.36M derived: sum of 3 quarters · filed 2026-08-10 | $24.24M 10-K · filed 2026-03-12 | ||||||||||||||
| 2025-09-30 | $10.16M 10-Q · filed 2025-11-12 | $15.24M derived: sum of 2 quarters · filed 2026-08-10 | $20.13M 10-Q · filed 2025-11-12 | |||||||||||||||
| 2025-06-30 | $5.08M 10-Q · filed 2026-08-10 | $9.96M 10-Q · filed 2026-08-10 | ||||||||||||||||
| 2025-03-31 | $4.88M 10-Q · filed 2026-05-13 | |||||||||||||||||
| 2024-12-31 | $14.92M 10-K · filed 2026-03-12 | |||||||||||||||||
| 2024-09-30 | $9.00M 10-Q · filed 2025-11-12 | $9.68M derived: sum of 2 quarters · filed 2025-11-12 | $9.77M 10-Q · filed 2025-11-12 | $9.80M derived: sum of 3 quarters · filed 2025-11-12 | $9.94M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||||
| 2024-06-30 | $683.00K 10-Q · filed 2025-08-11 | $112.00K 10-Q · filed 2024-08-01 | $768.00K 10-Q · filed 2025-08-11 | $226.00K 10-Q · filed 2024-08-01 | $938.00K derived: sum of 3 quarters · filed 2025-08-11 | $1.09M derived: sum of 4 quarters · filed 2025-08-11 | ||||||||||||
| 2024-03-31 | $85.00K 10-Q · filed 2025-05-14 | $114.00K 10-Q · filed 2024-04-25 | $255.00K derived: sum of 2 quarters · filed 2024-04-25 | $409.00K derived: sum of 3 quarters · filed 2024-04-25 | $596.00K derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||
| 2023-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $295.00K derived: sum of 2 quarters · filed 2024-02-01 | $482.00K derived: sum of 3 quarters · filed 2024-08-01 | $686.00K 10-K · filed 2024-02-01 | ||||||||||||||
| 2023-09-30 | $154.00K 10-Q · filed 2023-10-18 | $341.00K derived: sum of 2 quarters · filed 2024-08-01 | $545.00K 10-Q · filed 2023-10-18 | $665.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||||
| 2023-06-30 | $187.00K 10-Q · filed 2024-08-01 | $391.00K 10-Q · filed 2024-08-01 | $511.00K derived: sum of 3 quarters · filed 2024-08-01 | $608.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||||
| 2023-03-31 | $204.00K 10-Q · filed 2024-04-25 | $324.00K derived: sum of 2 quarters · filed 2024-04-25 | $421.00K derived: sum of 3 quarters · filed 2024-04-25 | $593.00K derived: sum of 4 quarters · filed 2024-04-25 | ||||||||||||||
| 2022-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $217.00K derived: sum of 2 quarters · filed 2024-02-01 | $389.00K derived: sum of 3 quarters · filed 2024-02-01 | $556.00K 10-K · filed 2024-02-01 | ||||||||||||||
| 2022-09-30 | $97.00K 10-Q · filed 2023-10-18 | $269.00K derived: sum of 2 quarters · filed 2023-10-18 | $436.00K 10-Q · filed 2023-10-18 | $555.00K derived: sum of 4 quarters · filed 2023-10-18 | ||||||||||||||
| 2022-06-30 | $172.00K 10-Q · filed 2023-07-21 | $339.00K 10-Q · filed 2023-07-21 | $458.00K derived: sum of 3 quarters · filed 2023-07-21 | $562.00K derived: sum of 4 quarters · filed 2023-07-21 | ||||||||||||||
| 2022-03-31 | $167.00K 10-Q · filed 2023-04-24 | $286.00K derived: sum of 2 quarters · filed 2023-04-24 | $390.00K derived: sum of 3 quarters · filed 2023-04-24 | $523.00K derived: sum of 4 quarters · filed 2023-04-24 | ||||||||||||||
| 2021-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $223.00K derived: sum of 2 quarters · filed 2023-02-24 | $356.00K derived: sum of 3 quarters · filed 2023-02-24 | $497.00K 10-K · filed 2023-02-24 | ||||||||||||||
| 2021-09-30 | $104.00K 10-Q · filed 2022-10-28 | $237.00K derived: sum of 2 quarters · filed 2022-10-28 | $378.00K 10-Q · filed 2022-10-28 | $396.00K derived: sum of 4 quarters · filed 2022-10-28 | ||||||||||||||
| 2021-06-30 | $133.00K 10-Q · filed 2022-08-02 | $274.00K 10-Q · filed 2022-08-02 | $292.00K derived: sum of 3 quarters · filed 2022-08-02 | $297.00K derived: sum of 4 quarters · filed 2022-08-02 | ||||||||||||||
| 2021-03-31 | $141.00K 10-Q · filed 2022-05-02 | $159.00K derived: sum of 2 quarters · filed 2022-05-02 | $164.00K derived: sum of 3 quarters · filed 2022-05-02 | $168.00K derived: sum of 4 quarters · filed 2022-05-02 | ||||||||||||||
| 2020-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $23.00K derived: sum of 2 quarters · filed 2022-03-14 | $27.00K derived: sum of 3 quarters · filed 2022-03-14 | $43.00K 10-K · filed 2022-03-14 | ||||||||||||||
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-02 | $9.00K derived: sum of 2 quarters · filed 2021-11-02 | $25.00K 10-Q · filed 2021-11-02 | $52.00K derived: sum of 4 quarters · filed 2021-11-02 | ||||||||||||||
| 2020-06-30 | $4.00K 10-Q · filed 2021-08-04 | $20.00K 10-Q · filed 2021-08-04 | $47.00K derived: sum of 3 quarters · filed 2021-08-04 | $76.00K derived: sum of 4 quarters · filed 2021-08-04 | ||||||||||||||
| 2020-03-31 | $16.00K 10-Q · filed 2021-05-11 | $43.00K derived: sum of 2 quarters · filed 2021-05-11 | $72.00K derived: sum of 3 quarters · filed 2021-05-11 | $117.00K derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||||
| 2019-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $56.00K derived: sum of 2 quarters · filed 2021-03-18 | $101.00K derived: sum of 3 quarters · filed 2021-03-18 | $151.00K 10-K · filed 2021-03-18 | ||||||||||||||
| 2019-09-30 | $29.00K 10-Q · filed 2020-11-02 | $74.00K derived: sum of 2 quarters · filed 2020-11-02 | $124.00K 10-Q · filed 2020-11-02 | $182.00K derived: sum of 4 quarters · filed 2020-11-02 | ||||||||||||||
| 2019-06-30 | $45.00K 10-Q · filed 2020-08-05 | $95.00K 10-Q · filed 2020-08-05 | $153.00K derived: sum of 3 quarters · filed 2020-08-05 | $211.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | $50.00K 10-Q · filed 2020-05-06 | $108.00K derived: sum of 2 quarters · filed 2020-05-06 | $166.00K derived: sum of 3 quarters · filed 2020-05-06 | $226.00K derived: sum of 4 quarters · filed 2020-05-06 | ||||||||||||||
| 2018-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $116.00K derived: sum of 2 quarters · filed 2020-02-18 | $176.00K derived: sum of 3 quarters · filed 2020-02-18 | $273.00K 10-K · filed 2020-02-18 | ||||||||||||||
| 2018-09-30 | $58.00K 10-Q · filed 2019-11-06 | $118.00K derived: sum of 2 quarters · filed 2019-11-06 | $215.00K 10-Q · filed 2019-11-06 | $334.00K derived: sum of 4 quarters · filed 2019-11-06 | ||||||||||||||
| 2018-06-30 | $60.00K 10-Q · filed 2019-08-01 | $157.00K 10-Q · filed 2019-08-01 | $276.00K derived: sum of 3 quarters · filed 2019-08-01 | $395.00K derived: sum of 4 quarters · filed 2019-08-01 | ||||||||||||||
| 2018-03-31 | $97.00K 10-Q · filed 2019-05-08 | $216.00K derived: sum of 2 quarters · filed 2019-05-08 | $335.00K derived: sum of 3 quarters · filed 2019-05-08 | $454.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||||||||||||
| 2017-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $238.00K derived: sum of 2 quarters · filed 2019-02-27 | $357.00K derived: sum of 3 quarters · filed 2019-02-27 | $458.00K 10-K · filed 2019-02-27 | ||||||||||||||
| 2017-09-30 | $119.00K 10-Q · filed 2018-11-14 | $238.00K derived: sum of 2 quarters · filed 2018-11-14 | $339.00K 10-Q · filed 2018-11-14 | $310.00K derived: sum of 4 quarters · filed 2018-11-14 | ||||||||||||||
| 2017-06-30 | $119.00K 10-Q · filed 2018-08-09 | $220.00K 10-Q · filed 2018-08-09 | $191.00K derived: sum of 3 quarters · filed 2018-08-09 | $458.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||
| 2017-03-31 | $101.00K 10-Q · filed 2018-05-08 | $72.00K derived: sum of 2 quarters · filed 2018-05-08 | $339.00K derived: sum of 3 quarters · filed 2018-05-08 | $522.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||||
| 2016-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $238.00K derived: sum of 2 quarters · filed 2018-03-22 | $421.00K derived: sum of 3 quarters · filed 2018-03-22 | $576.00K 10-K · filed 2018-03-22 | ||||||||||||||
| 2016-09-30 | $267.00K 10-Q · filed 2017-11-09 | $450.00K derived: sum of 2 quarters · filed 2017-11-09 | $605.00K 10-Q · filed 2017-11-09 | $750.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||||
| 2016-06-30 | $183.00K 10-Q · filed 2017-08-03 | $338.00K 10-Q · filed 2017-08-03 | $483.00K derived: sum of 3 quarters · filed 2017-08-03 | $632.00K derived: sum of 4 quarters · filed 2017-08-03 | ||||||||||||||
| 2016-03-31 | $155.00K 10-Q · filed 2017-05-15 | $300.00K derived: sum of 2 quarters · filed 2017-05-15 | $449.00K derived: sum of 3 quarters · filed 2017-05-15 | $624.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||||
| 2015-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $294.00K derived: sum of 2 quarters · filed 2017-03-21 | $469.00K derived: sum of 3 quarters · filed 2017-03-21 | $599.00K 10-K · filed 2017-03-21 | ||||||||||||||
| 2015-09-30 | $149.00K 10-Q · filed 2016-11-14 | $324.00K derived: sum of 2 quarters · filed 2016-11-14 | $454.00K 10-Q · filed 2016-11-14 | $610.00K derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||||
| 2015-06-30 | $175.00K 10-Q · filed 2016-08-09 | $305.00K 10-Q · filed 2016-08-09 | $461.00K derived: sum of 3 quarters · filed 2016-08-09 | $622.00K derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||||
| 2015-03-31 | $130.00K 10-Q · filed 2016-05-11 | $286.00K derived: sum of 2 quarters · filed 2016-05-11 | $447.00K derived: sum of 3 quarters · filed 2016-05-11 | $619.00K derived: sum of 4 quarters · filed 2016-05-11 | ||||||||||||||
| 2014-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $317.00K derived: sum of 2 quarters · filed 2016-03-17 | $489.00K derived: sum of 3 quarters · filed 2016-03-17 | $647.00K 10-K · filed 2016-03-17 | ||||||||||||||
| 2014-09-30 | $161.00K 10-Q · filed 2015-11-12 | $333.00K derived: sum of 2 quarters · filed 2015-11-12 | $491.00K 10-Q · filed 2015-11-12 | $649.00K derived: sum of 4 quarters · filed 2015-11-12 | ||||||||||||||
| 2014-06-30 | $172.00K 10-Q · filed 2015-08-11 | $330.00K 10-Q · filed 2015-08-11 | $488.00K derived: sum of 3 quarters · filed 2015-08-11 | $537.00K derived: sum of 4 quarters · filed 2015-08-11 | ||||||||||||||
| 2014-03-31 | $158.00K 10-Q · filed 2015-05-12 | $316.00K derived: sum of 2 quarters · filed 2015-05-12 | $365.00K derived: sum of 3 quarters · filed 2015-05-12 | $399.00K derived: sum of 4 quarters · filed 2015-05-12 | $3.03M 10-Q · filed 2014-05-13 | |||||||||||||
| 2013-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $207.00K derived: sum of 2 quarters · filed 2015-03-19 | $241.00K derived: sum of 3 quarters · filed 2015-03-19 | $283.00K 10-K · filed 2015-03-19 | $2.87M 10-K · filed 2014-03-20 | |||||||||||||
| 2013-09-30 | $49.00K 10-Q · filed 2014-11-12 | $83.00K derived: sum of 2 quarters · filed 2014-11-12 | $125.00K 10-Q · filed 2014-11-12 | $188.00K derived: sum of 4 quarters · filed 2014-11-12 | $2.71M 10-Q · filed 2013-11-13 | |||||||||||||
| 2013-06-30 | $34.00K 10-Q · filed 2014-08-13 | $76.00K 10-Q · filed 2014-08-13 | $139.00K derived: sum of 3 quarters · filed 2014-08-13 | $213.00K derived: sum of 4 quarters · filed 2014-08-13 | $2.66M 10-Q · filed 2013-08-13 | |||||||||||||
| 2013-03-31 | $42.00K 10-Q · filed 2014-05-13 | $105.00K derived: sum of 2 quarters · filed 2014-05-13 | $179.00K derived: sum of 3 quarters · filed 2014-05-13 | $257.00K derived: sum of 4 quarters · filed 2014-05-13 | $2.63M 10-Q · filed 2013-05-13 | |||||||||||||
| 2012-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $137.00K derived: sum of 2 quarters · filed 2014-03-20 | $215.00K derived: sum of 3 quarters · filed 2014-03-20 | $306.00K 10-K · filed 2014-03-20 | $2.59M 10-K · filed 2013-03-21 | |||||||||||||
| 2012-09-30 | $74.00K 10-Q · filed 2013-11-13 | $152.00K derived: sum of 2 quarters · filed 2013-11-13 | $243.00K 10-Q · filed 2013-11-13 | $319.00K derived: sum of 4 quarters · filed 2013-11-13 | $2.52M 10-Q · filed 2012-11-13 | |||||||||||||
| 2012-06-30 | $78.00K 10-Q · filed 2013-08-13 | $168.00K 10-Q · filed 2013-08-13 | $169.00K 10-Q · filed 2012-08-13 | $245.00K derived: sum of 3 quarters · filed 2013-08-13 | $324.00K derived: sum of 4 quarters · filed 2013-08-13 | $2.45M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $91.00K 10-Q · filed 2013-05-13 | $167.00K derived: sum of 2 quarters · filed 2013-05-13 | $246.00K derived: sum of 3 quarters · filed 2013-05-13 | $321.00K derived: sum of 4 quarters · filed 2013-05-13 | ||||||||||||||
| 2011-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $155.00K derived: sum of 2 quarters · filed 2013-03-21 | $230.00K derived: sum of 3 quarters · filed 2013-03-21 | $308.00K 10-K · filed 2013-03-21 | ||||||||||||||
| 2011-09-30 | $79.00K 10-Q · filed 2012-11-13 | $154.00K derived: sum of 2 quarters · filed 2012-11-13 | $232.00K 10-Q · filed 2012-11-13 | |||||||||||||||
| 2011-06-30 | $75.00K 10-Q · filed 2012-08-13 | $153.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |